Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Total Liabilities (2016 - 2025)

Dolby Laboratories' Total Liabilities history spans 17 years, with the latest figure at $589.3 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 8.16% year-over-year to $589.3 million; the TTM value through Dec 2025 reached $589.3 million, down 8.16%, while the annual FY2025 figure was $595.8 million, 4.37% down from the prior year.
  • Total Liabilities reached $589.3 million in Q4 2025 per DLB's latest filing, down from $595.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $646.0 million in Q1 2025 to a low of $438.5 million in Q3 2022.
  • Average Total Liabilities over 5 years is $544.6 million, with a median of $549.7 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: surged 38.55% in 2023, then dropped 15.84% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $462.4 million in 2021, then decreased by 1.38% to $456.0 million in 2022, then increased by 25.71% to $573.2 million in 2023, then increased by 11.92% to $641.6 million in 2024, then fell by 8.16% to $589.3 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Total Liabilities are $589.3 million (Q4 2025), $595.8 million (Q3 2025), and $581.8 million (Q2 2025).